T-Mobile US, Inc.
TMUS · Nasdaq, Nasdaq, Nasdaq, Nasdaq · CIK 0001283699
SIC 4812
Radiotelephone Communications
Category
Telecom
Entity
operating
Incorp.
DE
Fiscal Y/E
1231
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
$190.85
-2.78 (-1.44%)
Open
$192.34
High
$193.63
Low
$189.47
Prev Close
$193.63
Volume
4,443,107
52W High
$258.12
52W Low
$180.49
50-day MA
$203.62
Quote as of: 2026-05-11
Market Cap
$209.55B
P/E
20.58
P/B
3.75
PEG
0.77
EPS
9.41
BPS
53.48
Dividend Yield
2.03%
Beta
0.32
ROE
18.57%
ROA
5.01%
D/E Ratio
0.12
Current Ratio
1.00
Operating Margin
45.02%
Net Margin
27.07%
Book Value/Share
$53.48
Intrinsic Value Estimates
Multiple valuation methods, each with its own assumptions — outputs can diverge widely
Median consensus (7 methods)
$88.80B
| Method | Implied market cap | vs current |
|---|---|---|
Graham Number √(22.5 × 순이익 × 자본) | $121.00B | +73% |
Graham Formula 순이익 × (8.5 + 2 × 성장률%) | $26.16B | +701% |
Justified P/E 순이익 × 산업 평균 P/E | $164.88B | +27% |
P/B 배수 자본 × 산업 평균 P/B | $88.80B | +136% |
P/S 배수 매출 × 산업 평균 P/S | $81.21B | +158% |
DCF (Gordon) CF × (1+g) / (r − g) | $160.32B | +31% |
DDM (Gordon) D × (1+g) / (r − g) | $29.38B | +613% |
▶ Detailed analysis — formula walk-through & scenarios
Why this conclusion
Of the 7 valuation methods, 7 were applicable. Their median fair-value lands +136.0% below the current market cap → the stock trades above most formulas' estimates (overvalued). 7 methods flag overvalued, 0 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.
Graham Number
Overvalued +73.2%√(22.5 × 순이익 × 자본)
Current
$209.55B
Implied fair
$121.00B
Gap (current − fair)
+$88.54B(+73.2%)
NetIncome = $10.99B Equity = $59.20B √(22.5 × $10.99B × $59.20B) = $121.00B
- 최대 PER 15배
- 최대 PBR 1.5배
- 안정적 흑자 기업 가정 (금융·고성장 부정확)
Graham Formula
Overvalued +701.2%순이익 × (8.5 + 2 × 성장률%)
Current
$209.55B
Implied fair
$26.16B
Gap (current − fair)
+$183.39B(+701.2%)
NetIncome = $10.99B Growth g = -3.1% → cap -3.1% Multiple = 8.5 + 2 × -3.1 = 2.4× $10.99B × 2.4 = $26.16B
- EPS 성장률 -3.1%/년 가정 (직전 1년 기준)
- 무성장 기업 P/E = 8.5
- 현재 적용 배수: 2.4x
Justified P/E
Overvalued +27.1%순이익 × 산업 평균 P/E
Current
$209.55B
Implied fair
$164.88B
Gap (current − fair)
+$44.67B(+27.1%)
NetIncome = $10.99B Industry P/E = 15× $10.99B × 15 = $164.88B
- 산업 평균 PER 15x 가정 (사용자 정의 가능)
- 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장
P/B 배수
Overvalued +136.0%자본 × 산업 평균 P/B
Current
$209.55B
Implied fair
$88.80B
Gap (current − fair)
+$120.74B(+136.0%)
Equity = $59.20B Industry P/B = 1.5× $59.20B × 1.5 = $88.80B
- 산업 평균 PBR 1.5x 가정
- 은행·보험·자산집약적 산업에 특히 유효
P/S 배수
Overvalued +158.0%매출 × 산업 평균 P/S
Current
$209.55B
Implied fair
$81.21B
Gap (current − fair)
+$128.34B(+158.0%)
Revenue = $40.60B Industry P/S = 2× $40.60B × 2 = $81.21B
- 산업 평균 PSR 2x 가정
- 매출 기반 — 적자 기업·신생 기업에 적용 가능
- 이익률 차이 무시
DCF (Gordon)
Overvalued +30.7%CF × (1+g) / (r − g)
Current
$209.55B
Implied fair
$160.32B
Gap (current − fair)
+$49.23B(+30.7%)
FCF = $18.00B Discount r = 4.0% + 5.0% = 9.0% Growth g = -2.0% $18.00B × (1 + -2.0%) / (9.0% − -2.0%) = $160.32B
- 현금흐름 입력: FCF (잉여현금흐름)
- 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
- 영구 성장률 -2.0% (실질 GDP 수준)
DDM (Gordon)
Overvalued +613.3%D × (1+g) / (r − g)
Current
$209.55B
Implied fair
$29.38B
Gap (current − fair)
+$180.17B(+613.3%)
- 배당 입력: 순이익의 30% (이론적 배당 — 무배당주 평가용 가정)
- 할인율 9.0%
- 배당 영구 성장률 -2.0%
DCF sensitivity: discount rate × terminal growth
Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | -30.8% | -19.3% | -7.8% | +3.8% | +15.3% |
| 2% | -42.9% | -31.5% | -20.1% | -8.7% | +2.7% |
| 3% | -54.8% | -43.5% | -32.2% | -20.9% | -9.6% |
| 4% | -66.4% | -55.2% | -44.0% | -32.8% | -21.6% |
| 5% | -77.8% | -66.7% | -55.6% | -44.5% | -33.5% |
All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-02-11
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Income | 18,279 | 18,010 | 14,266 | 6,543 | 6,892 |
| Net Income | 10,992 | 11,339 | 8,317 | 2,590 | 3,024 |
| EPS (Basic) | 9.75 | 9.70 | 7.02 | 2.07 | 2.42 |
| EPS (Diluted) | 9.72 | 9.66 | 6.93 | 2.06 | 2.41 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 219,237 | 208,035 | 207,682 | 211,338 | 206,563 |
| Current Assets | 24,461 | 18,404 | 19,015 | 19,067 | 20,891 |
| Cash & Equivalents | 5,598 | 5,409 | 5,135 | 4,507 | 6,631 |
| Current Liabilities | 24,500 | 20,174 | 20,928 | 24,742 | 23,499 |
| Long-term Debt | 86,282 | 78,265 | 75,018 | 71,960 | 74,193 |
| Total Equity | 59,203 | 61,741 | 64,715 | 69,656 | 69,102 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 27,950 | 22,293 | 18,559 | 16,781 | 13,917 |
| Investing CF | -17,607 | -9,072 | -5,829 | -12,359 | -19,386 |
| Financing CF | -10,081 | -12,815 | -12,097 | -6,451 | 1,709 |
| CapEx | 9,955 | 8,840 | 9,801 | 13,970 | 12,326 |
📄 SEC Filings
Quarterly Report
TMUS FORM 10-Q
2026-04-28
Open →
Current Report
TMUS FORM 8-K
2026-04-28
Open →
Proxy Statement
DEF 14A
2026-04-27
Open →
Current Report
8-K
2026-04-23
Open →
Current Report
8-K
2026-03-31
Open →
Current Report
8-K
2026-03-27
Open →
Current Report
8-K
2026-02-19
Open →
Annual Report
TMUS FORM 10-K
2026-02-11
Open →
Current Report
8-K
2026-02-11
Open →
Current Report
TMUS FORM 8-K
2026-02-11
Open →
Current Report
8-K
2026-01-12
Open →
Current Report
8-K
2026-01-06
Open →
Current Report
8-K
2025-12-11
Open →
Current Report
8-K
2025-12-09
Open →
Quarterly Report
TMUS FORM 10-Q
2025-10-23
Open →
Current Report
TMUS FORM 8-K
2025-10-23
Open →
Current Report
8-K
2025-10-09
Open →
Other filings (83)
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
144
xsl144X01/primary_doc.xml
2026-05-01
Open →
S-3ASR
S-3ASR
2026-04-30
Open →
IRANNOTICE
TMUS IRAN NOTICE
2026-04-28
Open →
ARS
ARS
2026-04-27
Open →
DEFA14A
DEFA14A
2026-04-27
Open →
SCHEDULE 13D/A
xslSCHEDULE_13D_X02/primary_doc.xml
2026-03-23
Open →
Insider Transaction
FORM 4
2026-03-13
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
144
xsl144X01/primary_doc.xml
2026-03-10
Open →
Insider Transaction
FORM 4
2026-03-06
Open →
144
xsl144X01/primary_doc.xml
2026-03-04
Open →
Insider Transaction
FORM 4
2026-03-03
Open →
Insider Transaction
FORM 4
2026-03-03
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-25
Open →
Insider Transaction
FORM 4
2026-02-25
Open →
CERT
CERT
2026-02-25
Open →
144
xsl144X01/primary_doc.xml
2026-02-24
Open →
144
xsl144X01/primary_doc.xml
2026-02-24
Open →
Insider Transaction
FORM 4
2026-02-23
Open →
144
xsl144X01/primary_doc.xml
2026-02-23
Open →
8-A12B
8-A12B
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
144
xsl144X01/primary_doc.xml
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
144
xsl144X01/primary_doc.xml
2026-02-18
Open →
144
xsl144X01/primary_doc.xml
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
424B5
424B5
2026-02-17
Open →
144
xsl144X01/primary_doc.xml
2026-02-17
Open →
FWP
FWP
2026-02-12
Open →
144
xsl144X01/primary_doc.xml
2026-02-12
Open →
424B5
424B5
2026-02-12
Open →
IRANNOTICE
TMUS IRAN NOTICE
2026-02-11
Open →
424B5
424B5
2026-01-09
Open →
FWP
FWP
2026-01-08
Open →
424B5
424B5
2026-01-07
Open →
POSASR
POSASR
2026-01-07
Open →
144
xsl144X01/primary_doc.xml
2025-12-22
Open →
Insider Transaction
FORM 4
2025-12-15
Open →
Insider Transaction
FORM 4
2025-12-11
Open →
Insider Transaction
FORM 4
2025-12-09
Open →
144
xsl144X01/primary_doc.xml
2025-12-05
Open →
Insider Transaction
FORM 4
2025-12-04
Open →
Insider Transaction
FORM 4
2025-11-19
Open →
Insider Transaction
FORM 4
2025-11-19
Open →
144
xsl144X01/primary_doc.xml
2025-11-18
Open →
144
xsl144X01/primary_doc.xml
2025-11-17
Open →
144
xsl144X01/primary_doc.xml
2025-11-17
Open →
Insider Transaction
FORM 4
2025-11-12
Open →
144
xsl144X01/primary_doc.xml
2025-11-12
Open →
Insider Transaction
FORM 4
2025-11-10
Open →
Insider Transaction
FORM 4
2025-11-04
Open →
Insider Transaction
FORM 4
2025-11-04
Open →
Insider Transaction
xslF345X05/form4.xml
2025-10-31
Open →
Insider Transaction
FORM 4
2025-10-29
Open →
Insider Transaction
FORM 4
2025-10-27
Open →
Insider Transaction
FORM 4
2025-10-23
Open →
IRANNOTICE
TMUS IRAN NOTICE
2025-10-23
Open →
Insider Transaction
FORM 4
2025-10-21
Open →
Insider Transaction
FORM 4
2025-10-17
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2025-10-16
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X01/primary_doc.xml
2025-10-15
Open →
Insider Transaction
FORM 4
2025-10-14
Open →
Insider Transaction
FORM 4
2025-10-10
Open →
424B5
424B5
2025-10-08
Open →
Insider Transaction
FORM 4
2025-10-08
Open →
SCHEDULE 13D/A
xslSCHEDULE_13D_X01/primary_doc.xml
2025-10-06
Open →
FWP
FWP
2025-10-06
Open →
Insider Transaction
FORM 4
2025-10-06
Open →
424B5
424B5
2025-10-06
Open →
POSASR
POSASR
2025-10-06
Open →